Lv1
80 积分 2024-08-13 加入
0743 Vibrance-2: A Randomized Phase 2 Study Evaluating Efficacy and Safety of the Orexin 2 Receptor Agonist Alixorexton in Patients with Narcolepsy Type 2
1个月前
已关闭
Dopamine serotonin stabilizer RP5063: A randomized, double-blind, placebo-controlled multicenter trial of safety and efficacy in exacerbation of schizophrenia or schizoaffective disorder
1个月前
已完结
Abstract IA012: REGN10597: A PD-1-targeted, receptor-masked wild type IL-2 with improved therapeutic window for cancer immunotherapy
1个月前
已完结
Vepdegestrant, a PROTAC Estrogen Receptor Degrader, in Advanced Breast Cancer
2个月前
已完结
NRX-101 (D-cycloserine plus lurasidone) vs. lurasidone for the maintenance of initial stabilization after ketamine in patients with severe bipolar depression with acute suicidal ideation and behavior: a randomized prospective phase 2 trial
2个月前
已关闭
Next steps for targeted protein degradation
2个月前
已完结
10.1177/02698811211073759
2个月前
已完结
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
2个月前
已完结
MicroRNA-212-3p regulates early neurogenesis through the AKT/mTOR pathway by targeting MeCP2
3个月前
已关闭
Factor XI inhibitors for the prevention and treatment of venous and arterial thromboembolism
4个月前
已完结
皖公网安备34019202002308
